Get the Stockscreener App
0.389
9.73%
0.0345
Pre-market:
.40
0.011
+2.83%
Processa Pharmaceuticals Inc stock is traded at $0.389, with a volume of 4.00M.
It is up +9.73% in the last 24 hours and up +102.71% over the past month.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
See More
Previous Close:
$0.3545
Open:
$0.3715
24h Volume:
4.00M
Relative Volume:
0.40
Market Cap:
$19.59M
Revenue:
-
Net Income/Loss:
$-12.88M
P/E Ratio:
-0.1676
EPS:
-2.3215
Net Cash Flow:
$-10.85M
1W Performance:
+25.40%
1M Performance:
+102.71%
6M Performance:
+50.89%
1Y Performance:
-66.32%
1-Day Range:
$0.36
$0.3995
1-Week Range:
$0.2923
$0.4337
52-Week Range:
$0.15
$1.50
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Name
Processa Pharmaceuticals Inc
Sector
Industry
Phone
443-776-3133
Address
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.389 | 19.79M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-24 | Initiated | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Stock (PCSA) Latest News
Analyzing Processa Pharmaceuticals Inc. with risk reward ratio chartsRate Hike & AI Enhanced Trading Alerts - newser.com
Can a trend reversal in Processa Pharmaceuticals Inc. lead to recovery2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Pattern recognition hints at Processa Pharmaceuticals Inc. upsidePortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Can you recover from losses in Processa Pharmaceuticals Inc.2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is Processa Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Volume & Free Community Supported Trade Ideas - newser.com
Published on: 2025-11-02 06:25:47 - newser.com
Is Processa Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
How Processa Pharmaceuticals Inc. stock compares to growth peersEarnings Overview Summary & Community Consensus Picks - newser.com
Is Processa Pharmaceuticals Inc a good long term investmentMomentum Stock Picks & Budget Friendly Trading Ideas - earlytimes.in
Relative strength of Processa Pharmaceuticals Inc. in sector analysisWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
Order flow analysis tools used on Processa Pharmaceuticals Inc.July 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Is Information Services Group Inc ZZG a good long term investmentMACD Histogram Signals & Discover High-Return Stocks Before They Boom - earlytimes.in
How to read the order book for Processa Pharmaceuticals Inc.Weekly Trading Summary & Verified Momentum Watchlists - newser.com
What data driven models say about Processa Pharmaceuticals Inc.’s futureBreakout Watch & Real-Time Buy Signal Alerts - newser.com
Quantitative breakdown of Processa Pharmaceuticals Inc. recent moveJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
Will Processa Pharmaceuticals Inc. stock sustain high P E ratiosJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Using data filters to optimize entry into Processa Pharmaceuticals Inc.Quarterly Performance Summary & Weekly High Return Stock Opportunities - newser.com
Published on: 2025-10-30 23:43:44 - newser.com
Processa Pharmaceuticals Advances Breast Cancer Treatment with Phase 2 Study - TipRanks
Applying Wyckoff theory to Processa Pharmaceuticals Inc. stock2025 Market WrapUp & Safe Entry Zone Tips - newser.com
Can Processa Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com
Is MillerKnoll Inc a good long term investmentRisk Mitigation Techniques & Superior Growth Trading - earlytimes.in
Will Processa Pharmaceuticals Inc. stock split again soonJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Rising Trends of Gastroparesis Treatment Market See Incredible - openPR.com
Is Processa Pharmaceuticals Inc. stock trading near support levelsRate Cut & Long-Term Capital Growth Strategies - newser.com
Is Processa Pharmaceuticals Inc. stock attractive for growth ETFsWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
Published on: 2025-10-28 00:26:04 - newser.com
Processa Pharmaceuticals Inc Stock (PCSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Processa Pharmaceuticals Inc Stock (PCSA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):